Products for Research Use Only
RegisterLogin

SU212

CAT: 0804-HY-179578Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-179578Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SU212 is a podophyllotoxin-derived ENO1 inhibitor and AMPK activator. SU212 can selectively induce oxidative phosphorylation, reduce glycolysis activity and glucose uptake in tumor cells, and directly bind to ENO1 without affecting these pathways in normal cells. SU212 induces apoptosis and promotes ENO1 degradation via proteasomal and autophagic pathways without inhibiting the catalytic activity. SU212 leads to mitotic arrest and apoptosis in TNBC (triple-negative breast cancer) cells by activating AMPK, demonstrating potent anti-tumor activity in vitro. SU212 inhibits tumor growth and metastasis in syngeneic, xenograft, and diabetic mouse models, exhibiting an excellent safety profile. SU212 can be used in research on t TNBC, diabetes, and fatty liver disease[1][2].
CAS Number
1262219-89-5
UNSPSC
12352005
Target
AMPK; Apoptosis; Autophagy; Caspase; Enolase; mTOR
Related Pathways
Apoptosis; Autophagy; Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Field of Research
Cancer; Metabolic Disease
Smiles
COC1=CC(C2C3=CC4=C(CCC4)C=C3N(C5=C2C(OC5)=O)CCO)=CC(OC)=C1OC
Molecular Formula
C25H27NO6
Molecular Weight
437.48
References & Citations
[1]Tailor D, et al., Malhotra SV. Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer. Cell Rep Med. 2025 Nov 18;6 (11) :102451.|[2]Tailor D, et al., Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer. Br J Cancer. 2021 Feb;124 (3) :604-615.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
GTR19274394-01SU212

Popular Products